DeepCT vs HALO

Direct competitors — feature-level head-to-head below. Comparability 80/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Deep01 Limited
VS
by Nico.Lab B.V.

AI Verdict

Both DeepCT and HALO offer AI-powered solutions for the rapid detection of intracranial hemorrhage and clinical decision support in emergency settings. DeepCT provides a broader scope for various brain abnormalities including TBI and fractures from non-contrast CTs, while HALO specializes in acute stroke patients, specifically focusing on large vessel occlusion detection and facilitating evaluation of brain vasculature on CT angiograms.

Choose DeepCT if…

Choose DeepCT if your primary need is a comprehensive AI solution for rapid detection and triage of a wide range of brain abnormalities, including ICH, TBI, midline shift, and fractures, from non-contrast CT scans in an emergency setting. This tool is ideal for improving general emergency department workflow and patient outcomes by prioritizing diverse time-sensitive cases beyond just acute stroke.

View DeepCT →

Choose HALO if…

Choose HALO if your focus is specifically on optimizing the acute stroke pathway, requiring rapid AI-powered detection of large vessel occlusions (LVO) and intracerebral hemorrhage (ICH). This cloud-based tool is particularly well-suited for facilities needing timely notifications to specialists and advanced evaluation of brain vasculature on CT angiograms to facilitate quick decision-making in stroke management.

View HALO →

When choosing between DeepCT and HALO, physicians should consider their primary focus in acute neurological imaging. DeepCT, developed by Deep01 Limited, offers a broader scope for detecting various brain abnormalities from non-contrast CT scans. It excels in identifying intracranial hemorrhage (ICH), midline shift, acute stroke, traumatic brain injury (TBI), and fractures, providing features like segmentation and quantification of ICH and worklist prioritization. This makes DeepCT particularly well-suited for emergency departments or radiology practices requiring a comprehensive AI tool for general head CT interpretation and triage of time-sensitive cases.

In contrast, HALO by Nico.Lab B.V. is specifically optimized for acute stroke diagnosis and management. Its core strengths lie in the rapid detection of large vessel occlusions (LVO) and intracerebral hemorrhage (ICH), including volume quantification, primarily from CT angiograms. HALO’s cloud-based platform and automated notifications to specialists are designed to streamline the stroke care pathway. The key practical difference is DeepCT’s wider range of detectable brain abnormalities versus HALO’s specialized focus on acute stroke, particularly LVO. Therefore, a physician whose practice heavily involves acute stroke evaluation and management would likely find HALO more tailored to their needs, while a physician seeking a more general-purpose AI assistant for head CT interpretation across various emergent conditions would benefit more from DeepCT.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature DeepCT HALO
Pricing Contact for details Not disclosed
Deployment Cloud-based, Hybrid solution, Locally on dedicated hardware, Integration in standard reading environment (PACS), Stand-alone third party application, Stand-alone web-based Cloud-based (Google Cloud Platform)
FDA Status Yes AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

HALO

HALO offers an intuitive app and an 'On-the-Go Viewer' that allows streaming of full DICOM series in under 10 seconds, enabling rapid remote review on smartphones. This mobile accessibility and speed are particularly beneficial for acute stroke management where timely access to images is critical. DeepCT also offers flexible deployment and is described as user-friendly, but HALO's emphasis on mobile-first, rapid remote review gives it an edge for urgent clinical scenarios.

Clinical Value

DeepCT

DeepCT provides a broader range of detection capabilities, including intracranial hemorrhage (ICH), acute stroke, traumatic brain injury (TBI), fractures, midline shift, and LVO, from non-contrast CT scans. This comprehensive scope makes it valuable for a wider array of emergency department presentations beyond just acute stroke. DeepCT has also demonstrated a reduction in ICH patients' length of stay in the ED by an average of 3 hours and 40 minutes.

Pricing & Value

Tie

Neither DeepCT nor HALO disclose their pricing models or specific costs in the provided information or publicly available web searches. Both require direct contact with the vendor for pricing details. Therefore, it is impossible to conduct a head-to-head comparison on this dimension and determine a winner.

Enterprise Readiness

DeepCT

DeepCT offers a wider array of deployment options, including cloud-based, hybrid solutions, and local deployment on dedicated hardware, alongside integration into standard PACS environments. This flexibility caters to diverse enterprise IT infrastructures and security requirements. While HALO is FDA-cleared and explicitly states HIPAA compliance and BAA availability, DeepCT's broader deployment choices provide greater adaptability for various hospital networks.

Innovation

HALO

HALO demonstrates strong innovation through its specialized focus on acute stroke, particularly with its AI-powered Large Vessel Occlusion (LVO) detection and the recently FDA-cleared CT Perfusion algorithm. These features are highly targeted and impactful for a time-sensitive condition where rapid and precise diagnosis significantly influences patient outcomes. While DeepCT covers a broad range of detections, HALO's advanced, specialized stroke workflow tools represent a more focused and cutting-edge innovation in its niche.

Support & Docs

Tie

No specific information regarding customer support channels, service level agreements, or documentation availability was provided for either DeepCT or HALO in the structured facts or through web searches. Without this crucial information, it is not possible to assess or compare their support and documentation offerings. Therefore, this dimension results in a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature DeepCT HALO
Company Deep01 Limited Nico.Lab B.V.
Tagline World-Leading AI-Powered Detection System for Head CT AI-powered clinical support for acute stroke diagnosis and management.
Categories Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Specialties Emergency Medicine, Neurology, Radiology Emergency Medicine, Neurology, Radiology
Key Features Detection of intracranial hemorrhage (ICH), Notification to clinicians for suspected findings, Segmentation and quantification of ICH, Worklist prioritization for time-sensitive cases, Detection of midline shift, Detection of acute stroke, Detection of traumatic brain injury (TBI), Detection of fractures AI-powered Large Vessel Occlusion (LVO) detection, Intracerebral Hemorrhage (ICH) detection and volume quantification, Cloud-based image processing and analysis, Automated notifications to medical specialists, Remote review via compatible DICOM web viewer, Facilitates evaluation of brain vasculature on CT angiograms, Triage function for stroke patients, DICOM / PACS integration

Videos

Demos, reviews, and walkthroughs featuring DeepCT and HALO.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

DeepCT is designed for rapid detection and triage of suspected intracranial hemorrhage (ICH) and other brain abnormalities, including midline shift, acute stroke, traumatic brain injury (TBI), and fractures from non-contrast CT scans. HALO focuses on the rapid detection of large vessel occlusions (LVOs) and intracerebral hemorrhage (ICH) specifically in acute stroke patients.
HALO explicitly features AI-powered Large Vessel Occlusion (LVO) detection and facilitates the evaluation of brain vasculature on CT angiograms. DeepCT mentions detection of acute stroke, but does not specifically detail LVO detection as a key feature.
DeepCT provides segmentation and quantification of ICH, detection of midline shift, and worklist prioritization for time-sensitive cases. HALO offers ICH detection and volume quantification, automated notifications to medical specialists, remote review via a compatible DICOM web viewer, and a triage function for stroke patients.
AI Tool Finder
AI-powered search. Results may not be comprehensive.